USANA Health Sciences (USNA) Reports Mixed Q4 Results and Guidance
Get Alerts USNA Hot Sheet
Price: $42.90 -1.83%
Revenue Growth %: -9.9%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -9.9%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.65, $0.28 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $219.1 million.
USANA Health Sciences sees FY2015 EPS of $6.40-$6.70, versus the consensus of $6.73. USANA Health Sciences sees FY2015 revenue of $850-870 million, versus the consensus of $823.55 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- Ladder Capital (LADR) Tops Q1 EPS by 4c
- Deutsche Bank (DB) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!